POSSIBLE SERIOUS SIDE EFFECTS:
Possible serious side effects include:
- Reduced white blood cells
- Reduced red blood cells (anemia)
- Reduced number of platelets
- Low blood pressure
- High blood pressure
PREPARATIONS: Injection (single use vial): 30 mg/vial
DRUG INTERACTIONS: Alemtuzumab drug interaction studies have not been conducted.
PREGNANCY AND BREASTFEEDING SAFETY:
- Proteins such as alemtuzumab, may cross the placental barrier and may be excreted in breast milk. Alemtuzumab has not been studied in pregnant women or nursing mothers. It should be given to a pregnant or nursing woman only if clearly needed.
STORAGE: Alemtuzumab should be stored at 2 C to 8 C (36 F to 46 F), protected from light, and not frozen. If frozen, thaw to 2 to 8 C before administration.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.